Related Experiment Videos
Poly(dimethylsiloxane) coatings for controlled drug release--polymer modifications
J Schulze Nahrup1, Z M Gao, J E Mark
1Industrial Pharmacy Graduate Program, University of Cincinnati Medical Center, 3223 Eden Avenue, Cincinnati, OH 45267-0004, USA.
International Journal of Pharmaceutics
|January 17, 2004
Summary
Modified poly(dimethylsiloxane) (PDMS) coatings with polyethylene glycol (PEG) enabled zero-order drug release from tablets. Higher PEG concentrations achieved sustained release over 24 hours.
Area of Science:
- Materials Science
- Pharmaceutical Technology
- Polymer Chemistry
Background:
- End-hydroxylated poly(dimethylsiloxane) (PDMS) formulations require modification for controlled drug delivery applications.
- Spray-coating processes necessitate specific material properties for effective tablet coating.
Purpose of the Study:
- To investigate modified PDMS formulations for spray-coating tablet cores.
- To achieve zero-order drug release kinetics using these modified coatings.
- To evaluate the impact of crosslinker and channeling agent variations on coating properties and drug release.
Main Methods:
- Modified PDMS formulations using different crosslinkers (TEOS, SIG) and channeling agents (lactose, MCC, PEG).
- Characterization of dispersion properties (particle size, viscosity) and mechanical properties of free films.
- In vitro release studies of hydrochlorothiazide from coated tablets in a conventional coating pan.
Main Results:
- All PDMS dispersions were suitable for spray-coating.
- Copolymer addition negatively impacted mechanical properties, precluding its use in free films.
- Formulations with polyethylene glycol (PEG) were most effective for controlling drug release, even at low coating weights (5%).
- Constant release rates were achieved with up to 25% PEG, with 50% PEG yielding 63% drug release over 24 hours.
Conclusions:
- Modified PDMS formulations, particularly those incorporating PEG, are promising for developing controlled-release tablet coatings.
- PEG acts as an effective channeling agent, enabling tunable zero-order drug release profiles.
- Further optimization of PEG concentration can achieve sustained drug release over extended periods.